Nephro Care India Limited
NEPHROCARE (NSE) · NEPHROCARE (BSE 211745) · ISIN INE0SUN01013 · Hospital · listed 2024
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹29.19 cr and profit after tax ₹1.61 cr.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹29.19 cr | ₹1.61 cr | 0.98 | 8 Aug 2026 |
| Q4 FY26 standalone | ₹26.75 cr | ₹1 cr | 0.61 | 27 May 2026 |
| Q3 FY26 standalone | ₹22.66 cr | ₹0.42 cr | 0.00 | 13 Feb 2026 |
| Q4 FY24 standalone | ₹27.23 cr | ₹0 cr | 3.80 | 20 Sep 2024 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹56.85 cr | ₹0 cr | ₹72.67 cr |
| 30 Sep 2025 standalone | ₹55.43 cr | ₹0 cr | ₹66.9 cr |
| 31 Mar 2025 standalone | ₹53.48 cr | ₹0 cr | ₹68.28 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 61.71% | 0.73% | 0.86% | 38.29% |
Latest filings
- Annual Report FY2025-26 (New) 26 August 2026 · NSE
- Nephro Care India Limited has informed the Exchange regarding Outcome of Board Meeting held on August 07, 2026. 7 August 2026 · NSE
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. 7 August 2026 · NSE
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 27 May 2026 · NSE
- Nephro Care India Limited has informed the Exchange regarding Board meeting held on February 13, 2026. 13 February 2026 · NSE
Other companies in Hospital
- Apollo Hospitals Enterprise Limited
- Narayana Hrudayalaya Ltd.
- Global Health Limited
- Max Healthcare Institute Limited
- Aster DM Quality Care Limited
- Fortis Healthcare Limited
- Krishna Institute of Medical Sciences Limited
- Rainbow Childrens Medicare Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 September 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.